| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/27/2008 | CN101249218A Chinese medicine prescription for curing glaucoma |
| 08/27/2008 | CN101249175A Chinese medicine prescription for curing myopic eye disease and production method of preparations |
| 08/27/2008 | CN101249156A Proprietary Chinese medicine preparations for curing quasi-molecule laser postoperative acute ophthalmodynia and method of preparing the same |
| 08/27/2008 | CN101249136A Applications of compound red sage root tablet for pharmacy |
| 08/27/2008 | CN101249129A Chinese medicine extract combination and medicine use thereof |
| 08/27/2008 | CN101249126A Preparation technique of reducing fever powder capsule |
| 08/27/2008 | CN101249094A Use of synthetic vitamin B1 derivative for preparing ophthalmocace medicament |
| 08/27/2008 | CN101249065A Gelatin for Balofloxacin eye and method of preparing the same |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
| 08/27/2008 | CN100413852C Valsartan salts |
| 08/27/2008 | CN100413538C Remedy for corneal failure |
| 08/27/2008 | CN100413505C Gel agent for treating glaucoma and its preparing process |
| 08/27/2008 | CN100413503C Compound ocular medicinal composition |
| 08/27/2008 | CN100413498C Drop pills of soybean aglycone, and preparation method |
| 08/27/2008 | CN100413497C Water soluble soybean aglycone medicinal composition and its preparing method |
| 08/26/2008 | US7417067 mixtures of bicyclic compounds such as lubiprostone, and triglycerides; bronchodilator agents; eye drops, capsules |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | CA2392165C Vitamin d analogues |
| 08/26/2008 | CA2323810C Ophthalmic solution comprising glycogen |
| 08/26/2008 | CA2208981C Novel trienoic retinoid compounds and methods |
| 08/26/2008 | CA2160779C Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 08/21/2008 | WO2008101195A2 Drug resistance reversal in neoplastic disease |
| 08/21/2008 | WO2008101052A2 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract |
| 08/21/2008 | WO2008100809A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure |
| 08/21/2008 | WO2008100807A2 Ophthalmic compositions containing a synergistic combination of three polymers |
| 08/21/2008 | WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008099908A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | WO2008099805A1 Central circulation-improving agent |
| 08/21/2008 | WO2008099804A1 Therapeutic agent for diabetic cataract |
| 08/21/2008 | WO2008099781A1 Therapeutic or prophylactic agent for demyelinating disease comprising amino alcohol derivative as active ingredient |
| 08/21/2008 | WO2008098299A1 Methods and systems of treating age-related macular degeneration |
| 08/21/2008 | WO2008075148A3 Tricyclic inhibitors of carbonic anhydrase |
| 08/21/2008 | WO2008066641A3 Methods for treating mitf associated diseases by the use of methionine aminopeptidase-2 inhibitors |
| 08/21/2008 | WO2008060377A3 Placental or umbilical cord tissue compositions |
| 08/21/2008 | US20080200399 Taurine, cysteic acid residue and residue of a protease or calpain inhibitor; directly, indirectly bonded to each other;leucyl argininal residues in form of aldehyde; effective to inhibit calpains; acetal prodrug residues can be converted to the aldehyde form before, during, or after administration |
| 08/21/2008 | US20080200378 KGF polypeptide compositions |
| 08/21/2008 | US20080200367 Compositions and Methods for Treating Sleep Disorders |
| 08/21/2008 | US20080199537 Topical gatifloxacin formulations |
| 08/21/2008 | US20080199498 In situ administering Clostridium toxin; antiinflammatory agents |
| 08/21/2008 | US20080199400 Otologic nanotechnology |
| 08/21/2008 | DE202008007806U1 Substanz zur Behandlung otologischer Störungen Substance for the treatment otologic disorders |
| 08/21/2008 | CA2678432A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | CA2678363A1 Drug resistance reversal in neoplastic disease |
| 08/21/2008 | CA2678191A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure |
| 08/21/2008 | CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2675601A1 Ophthalmic compositions containing a synergistic combination of three polymers |
| 08/20/2008 | EP1958949A1 Therapeutic agent for corneal/conjuctival disease |
| 08/20/2008 | EP1957451A1 Soft anticholinergic zwitterions |
| 08/20/2008 | EP1380302B1 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 08/20/2008 | EP1331902B1 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 08/20/2008 | EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1210947B1 Ophthalmic ointment comprising vancomycin hydrochloride for treating infective eye diseases |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | EP0703897B1 Lipoxin compounds with prolonged half-life |
| 08/20/2008 | CN101245106A Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 08/20/2008 | CN101244256A Micro/sub-micro emulsion in situ gel rubber preparation of cyclosporins A for eyes and preparation thereof |
| 08/20/2008 | CN101244126A Composition for treating eye disease and preparation method |
| 08/20/2008 | CN101244076A Pharmaceutical combination of azithromycin for eyes |
| 08/20/2008 | CN101244035A Cyclosporins A emulsion preparations for eyes and preparation thereof |
| 08/20/2008 | CN100411686C Visual function improving agents |
| 08/20/2008 | CN100411656C Application of cocoa ted extract in preparation of anti arteriosclerosis, antiageing medicine food and cosmetics |
| 08/20/2008 | CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/20/2008 | CN100411617C Use of flavone compounds in preparing medicament |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 08/19/2008 | CA2621616A1 Topical gatifloxacin formulations |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/14/2008 | WO2008098027A2 Treatment of ischemic retinal conditions with memantine |
| 08/14/2008 | WO2008097317A1 Solvating system and sealant for medical use |
| 08/14/2008 | WO2008096870A1 Aza-bridged-ring compound |
| 08/14/2008 | WO2008096804A1 Eye drop preparation comprising latanoprost |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors |
| 08/14/2008 | WO2008075149A3 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 08/14/2008 | WO2007064752A3 Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
| 08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
| 08/14/2008 | US20080194649 Mixture of parasympathetic agents and sympathetic agent and local anesthetic; injection into eye before laser therapy |
| 08/14/2008 | US20080194627 Aryl substituted pyridines and the use thereof |
| 08/14/2008 | US20080194531 Methods for Treating Visual Disorders |
| 08/14/2008 | US20080194515 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening |
| 08/14/2008 | US20080194468 Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
| 08/14/2008 | US20080193572 Extracts of Ginkgo Biloba |
| 08/14/2008 | US20080193558 Stabilized and preserved ketotifen ophth almic compositions |
| 08/14/2008 | CA2678193A1 Aza-bridged-ring compound |
| 08/14/2008 | CA2676081A1 Solvating system and sealant for medical use |
| 08/13/2008 | EP1954295A1 Composition having effect on treatment and prevention of dry eye syndrome |
| 08/13/2008 | EP1954261A2 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 08/13/2008 | EP1768657B1 Methods and compositions for treating ophthalmic conditions with retinyl derivates |
| 08/13/2008 | EP1740164B1 Statins for the treatment of ocular hypertension and glaucoma |
| 08/13/2008 | EP1489076B1 Cyclic hemiacetal derivative and use thereof |
| 08/13/2008 | EP1313415B1 Devices for intraocular drug delivery |
| 08/13/2008 | EP1289916B1 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | CN101242875A Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |